Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    Lupin launches Generic Pneumonia Drug Atovaquone Oral Suspension USP in USLupin launches Generic Pneumonia Drug Atovaquone Oral Suspension USP in US
    Aurobindo to acquire under development product, related assets from Advent for Rs 90 croreAurobindo to acquire under development product, related assets from Advent for Rs 90 crore
    Sun Pharma Q2 consolidated net loss at Rs 219 croreSun Pharma Q2 consolidated net loss at Rs 219 crore
    Roches Tecentriq gets instant FDA review in tough-to-treat breast cancerRoche's Tecentriq gets instant FDA review in tough-to-treat breast cancer
    Glenmark teams up with South Korean firm SCD for ophthalmic productsGlenmark teams up with South Korean firm SCD for ophthalmic products
    Theravance, Mylan win USFDA approval for COPD Drug YupelriTheravance, Mylan win USFDA approval for COPD Drug Yupelri
    Lupin gets EIR from USFDA for its Nagpur facilityLupin gets EIR from USFDA for its Nagpur facility
    Nestle raises stake in food allergy drug developer AimmuneNestle raises stake in food allergy drug developer Aimmune
    Lupin gets USFDA nod for Asthma drugLupin gets USFDA nod for Asthma drug
    Cipla gets USFDA nod for anti-viral eye infection drug for AIDS patientsCipla gets USFDA nod for anti-viral eye infection drug for AIDS patients
    Zydus Cadila gets USFDA nod for Anti-Fungal OintmentZydus Cadila gets USFDA nod for Anti-Fungal Ointment
    China mulls USD 720,000 fine for faking vaccine tests after scandalChina mulls USD 720,000 fine for faking vaccine tests after scandal
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    FDC Ban: Avoid These Combinations of Paracetamol

    FDC Ban: Avoid These Combinations of Paracetamol

    Delhi High Court directs RSSB chief Dhillon, family to undertake Singh brothers dues to Daiichi

    Delhi High Court directs RSSB chief Dhillon, family to undertake Singh brothers dues to Daiichi

    Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

    Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

    Health Minsitry bans 328 FDC Banned Drugs, check out the complete list

    Health Minsitry bans 328 FDC Banned Drugs, check out the complete list

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok